Free tool
Cell therapy stocks
We cover 85 companies grouped under the Cell therapy theme. The median market value in the group is $57.47M. Across the group, the median move over the past trading day is +0.56%. 41% of the 83 with a 200-day average trade above it. Price change over the past year runs from −73.8% to +88.7% across the middle 80 percent of the group, with a median of −20.4%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
85 of 86 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| LEGN | Legend Biotech Corporation | $21.30 | +10.53% | −0.98% | −38.44% |
| IOVA | Iovance Biotherapeutics, Inc. | $8.44 | +72.24% | +234.92% | +233.60% |
| MSB.AX | Mesoblast Limited | 2.40 AUD | +16.26% | −13.54% | −3.82% |
| MESO | Mesoblast Limited | $17.19 | +18.06% | −5.34% | +9.42% |
| VCEL | Vericel Corporation | $43.22 | −4.63% | +21.37% | +20.76% |
| BLFS | BioLife Solutions, Inc. | $37.22 | +24.94% | +55.80% | +45.11% |
| VOR | Vor Biopharma Inc. | $24.01 | +23.51% | +106.27% | −41.72% |
| SANA | Sana Biotechnology, Inc. | $4.10 | +25.00% | −2.15% | +22.39% |
| IMMX | Immix Biopharma, Inc. | $14.47 | +66.51% | +166.48% | +589.05% |
| SYNC.L | Syncona Limited | 111.40 GBP | +5.69% | +16.65% | +15.68% |
| CYRX | Cryoport, Inc. | $16.72 | +10.36% | +74.90% | +89.78% |
| ALLO | Allogene Therapeutics, Inc. | $2.17 | +24.00% | +60.74% | +87.07% |
| PROK | ProKidney Corp. | $1.73 | +12.34% | −22.42% | −26.38% |
| AUTL | Autolus Therapeutics plc | $2.44 | +67.12% | +30.48% | +52.50% |
| ARTV | Artiva Biotherapeutics, Inc. | $11.77 | +14.05% | +178.25% | +317.38% |
| KYTX | Kyverna Therapeutics, Inc. | $8.84 | +11.62% | +0.80% | +132.02% |
| CABA | Cabaletta Bio, Inc. | $3.22 | +18.38% | +45.70% | +102.52% |
| 0JDK.L | Iovance Biotherapeutics, Inc. | $8.36 | +1.91% | +222.92% | +248.46% |
| 4592.T | SanBio Company Limited | 1,024.00 JPY | +10.58% | −37.45% | −55.90% |
| CAPR | Capricor Therapeutics, Inc. | $8.29 | +18.43% | −70.72% | +25.61% |
| 005690.KS | Pharmicell Co., Ltd. | 10,830.00 KRW | +10.85% | −24.90% | +1.56% |
| 0HX7.L | Adicet Bio, Inc. | $9.03 | +0.56% | +5.00% | −24.75% |
| IPSC | Century Therapeutics, Inc. | $2.17 | +3.83% | +118.09% | +324.66% |
| LYEL | Lyell Immunopharma, Inc. | $15.49 | +19.52% | −46.55% | +41.20% |
| ALCLS.PA | Cellectis S.A. | 2.76 EUR | +9.63% | −34.61% | +19.05% |
| CLLS | Cellectis S.A. | $3.42 | +18.34% | −28.75% | +27.14% |
| 219A.T | HEARTSEED INC | 2,365.00 JPY | +36.94% | +31.02% | −32.33% |
| FATE | Fate Therapeutics, Inc. Common Stock | $2.55 | +4.94% | +157.58% | +133.94% |
| RNAC | Cartesian Therapeutics, Inc. | $10.38 | +33.25% | +53.55% | −7.73% |
| 4894.T | Cuorips Inc. | 5,670.00 JPY | +37.29% | −8.84% | −19.00% |
| LCTX | Lineage Cell Therapeutics, Inc. | $1.13 | +9.71% | −31.10% | −3.42% |
| 4593.T | Healios K.K. | 283.00 JPY | +25.22% | +0.71% | −40.92% |
| 7774.T | Japan Tissue Engineering Co., Ltd. | 875.00 JPY | +41.82% | +49.57% | +79.30% |
| NKTX | Nkarta, Inc. | $2.71 | +19.91% | +44.92% | +23.18% |
| 504A.T | Innovacell Inc. | 555.00 JPY | +17.34% | −47.14% | −47.14% |
| OCC.AX | Orthocell Limited | 0.78 AUD | +9.86% | −30.36% | −35.00% |
| MXCT | MaxCyte, Inc. | $1.35 | +32.35% | −12.90% | −2.88% |
| 0HIY.L | Atara Biotherapeutics, Inc. | $9.92 | +1.60% | −44.67% | −20.36% |
| ATRA | Atara Biotherapeutics, Inc. | $9.84 | +27.63% | −44.63% | −19.61% |
| ACET | Adicet Bio, Inc. | $9.00 | +11.66% | +2.04% | −20.89% |
| INKT | MiNK Therapeutics, Inc. | $11.38 | +7.46% | +2.34% | −21.89% |
| V3V.DE | FamiCord AG | 2.85 EUR | −3.06% | −52.89% | −60.69% |
| 7776.T | CellSeed Inc. | 234.00 JPY | +13.59% | −16.13% | −47.42% |
| 4896.T | K Pharma,Inc. | 773.00 JPY | +4.46% | +15.37% | +15.89% |
| 4584.T | Kidswell Bio Corporation | 180.00 JPY | +28.57% | −15.09% | −24.37% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | 580.00 GBP | −17.08% | +2.11% | +81.25% |
| ALA.AX | Arovella Therapeutics Limited | 0.06 AUD | −3.13% | −33.33% | −26.19% |
| ALPS | Alps Group Inc | $0.31 | −32.74% | −65.44% | −87.70% |
| TCRX | TScan Therapeutics, Inc. | $0.79 | +3.35% | −22.19% | −58.23% |
| 7096.T | StemCell Institute Inc. | 772.00 JPY | +6.63% | −2.03% | −21.54% |
| TVGN | Tevogen Inc. | $6.97 | +25.13% | −61.70% | −84.85% |
| 2370.T | MEDINET Co., Ltd. | 25.00 JPY | +4.17% | −13.79% | −34.21% |
| 3750.T | ADR Biomedical Holdings Inc. | 773.00 JPY | −0.64% | −9.48% | −15.61% |
| 4880.T | CellSource Co., Ltd. | 347.00 JPY | +10.51% | −13.25% | −41.78% |
| DTSQ | DT Cloud Star Acquisition Corporation | $11.33 | −0.18% | +4.72% | +8.42% |
| 4893.T | Noile-Immune Biotech Inc. | 148.00 JPY | +3.50% | +10.45% | −17.32% |
| PTG.WA | Poltreg S.A. | 25.20 PLN | +14.03% | −1.18% | −16.00% |
| 4892.T | Cyfuse Biomedical K.K. | 571.00 JPY | +10.66% | −5.93% | −9.22% |
| CCEL | Cryo-Cell International, Inc. | $4.30 | +30.30% | +25.36% | −0.92% |
| ESLA | Estrella Immunopharma, Inc. | $0.73 | −5.48% | −47.30% | −24.41% |
| SVA.TO | Sernova Biotherapeutics Inc | 0.11 CAD | −8.33% | −15.38% | −38.89% |
| PSH0.DE | Sernova Biotherapeutics Inc | 0.06 EUR | −9.73% | −26.71% | −46.78% |
| 0NLV.L | FamiCord AG | 2.78 EUR | −1.55% | −53.28% | −61.12% |
| LGVN | Longeveron Inc. | $0.68 | +11.29% | +14.67% | −12.71% |
| 311A.T | NPT Co Ltd | 680.00 JPY | 0.00% | −2.86% | −43.33% |
| NCEL | NewcelX Ltd. | $3.48 | −3.33% | +66.51% | −85.80% |
| PLUR | Pluri Inc. | $1.56 | −4.88% | −47.83% | −71.43% |
| BCDA | BioCardia, Inc. | $1.13 | +39.51% | −11.02% | −42.05% |
| SNTI | Senti Biosciences Holdings, Inc. | $0.39 | +4.52% | −64.46% | −75.42% |
| F98.F | CytoMed Therapeutics Limited | 0.75 EUR | −3.23% | −75.81% | −54.82% |
| INAB | IN8bio, Inc. | $1.17 | −1.68% | −52.44% | −46.58% |
| GDTC | CytoMed Therapeutics Limited | $0.94 | +3.89% | −32.73% | −52.59% |
| FBLG | FibroBiologics, Inc. | $1.40 | +123.29% | −70.83% | −88.54% |
| CMB.AX | Cambium Bio Limited | 0.42 AUD | −2.33% | −9.68% | 0.00% |
| CELZ | Creative Medical Technology Holdings, Inc. | $1.24 | +56.31% | −37.06% | −61.19% |
| 1AD.AX | AdAlta Limited | 0.00 AUD | −12.50% | −12.50% | −12.50% |
| ERNA | Ernexa Therapeutics Inc. | $4.93 | +25.64% | −83.02% | −86.22% |
| PMCB | PharmaCyte Biotech, Inc. | $0.53 | −10.26% | −28.86% | −48.78% |
| BRTX | BioRestorative Therapies, Inc. | $0.22 | −19.68% | −81.76% | −85.26% |
| 0QFK.L | Celyad Oncology SA | 0.26 EUR | −7.09% | +46.29% | −16.07% |
| MBIO | Mustang Bio, Inc. | $0.55 | −1.43% | −48.41% | −64.16% |
| BSFA.L | BSF Enterprise Plc | 1.25 GBP | +56.25% | −34.21% | −44.44% |
| CYP.AX | Cynata Therapeutics Limited | 0.01 AUD | −8.33% | −96.90% | −94.88% |
| CHM.AX | Chimeric Therapeutics Limited | 0.01 AUD | −65.79% | −93.50% | −95.67% |
| DTSQU | DT Cloud Star Acquisition Corporation | $11.49 | 0.00% | +4.95% | +9.95% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.